P

Propanc Biopharma Inc
D

PPCB

0.38550
USD
-0.03
(-7.11%)
قبل الجلسة·0.41800USD+0.03250(+8.43%)
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
100
الربح لكل سهم
0
العائد الربحي
-
P/E
-0
حجم السوق
3,789,895

العنوان: Propanc Biopharma Inc.

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.